IL86139A - 17-(cyclopropylamino) androst-5-en-3 ol and pharmaceutical compositions containing them, useful as c17-20 lyase inhibitors - Google Patents
17-(cyclopropylamino) androst-5-en-3 ol and pharmaceutical compositions containing them, useful as c17-20 lyase inhibitorsInfo
- Publication number
- IL86139A IL86139A IL86139A IL8613988A IL86139A IL 86139 A IL86139 A IL 86139A IL 86139 A IL86139 A IL 86139A IL 8613988 A IL8613988 A IL 8613988A IL 86139 A IL86139 A IL 86139A
- Authority
- IL
- Israel
- Prior art keywords
- androst
- cyclopropylamino
- useful
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4117287A | 1987-04-22 | 1987-04-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL86139A0 IL86139A0 (en) | 1988-11-15 |
| IL86139A true IL86139A (en) | 1993-02-21 |
Family
ID=21915133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL86139A IL86139A (en) | 1987-04-22 | 1988-04-20 | 17-(cyclopropylamino) androst-5-en-3 ol and pharmaceutical compositions containing them, useful as c17-20 lyase inhibitors |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0288053B1 (xx) |
| JP (1) | JP2711672B2 (xx) |
| KR (1) | KR960015037B1 (xx) |
| CN (1) | CN88102176A (xx) |
| AT (1) | ATE67211T1 (xx) |
| AU (1) | AU606677B2 (xx) |
| CA (1) | CA1326234C (xx) |
| DE (1) | DE3864725D1 (xx) |
| DK (1) | DK217588A (xx) |
| ES (1) | ES2038712T3 (xx) |
| FI (1) | FI88397C (xx) |
| GR (1) | GR3002713T3 (xx) |
| HU (1) | HU198511B (xx) |
| IL (1) | IL86139A (xx) |
| NO (1) | NO169346C (xx) |
| NZ (1) | NZ224288A (xx) |
| PH (1) | PH24090A (xx) |
| PT (1) | PT87294B (xx) |
| ZA (1) | ZA882717B (xx) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4891367A (en) * | 1987-04-22 | 1990-01-02 | Merrell Dow Pharmaceuticals Inc. | 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors |
| US4954488A (en) * | 1989-06-14 | 1990-09-04 | Merrell Dow Pharmaceuticals Inc. | Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives |
| US4966898A (en) * | 1989-08-15 | 1990-10-30 | Merrell Dow Pharmaceuticals Inc. | 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors |
| US5256408A (en) * | 1990-06-12 | 1993-10-26 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
| US5124154A (en) * | 1990-06-12 | 1992-06-23 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
| US5252319A (en) * | 1990-06-12 | 1993-10-12 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
| US5209926A (en) * | 1990-06-12 | 1993-05-11 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
| US5604213A (en) * | 1992-03-31 | 1997-02-18 | British Technology Group Limited | 17-substituted steroids useful in cancer treatment |
| DK0633893T3 (da) * | 1992-03-31 | 2000-04-17 | Btg Int Ltd | 17-Substituerede steroider, der er nyttige ved cancerbehandling |
| US5486511A (en) * | 1993-05-25 | 1996-01-23 | Merrell Dow Pharmaceuticals Inc. | 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase |
| CN100572363C (zh) | 2000-11-17 | 2009-12-23 | 武田药品工业株式会社 | 咪唑衍生物、其制备方法及其用途 |
| ATE502030T1 (de) | 2000-11-20 | 2011-04-15 | Takeda Pharmaceutical | Imidazolderivate, verfahren zu deren herstellung und deren verwendung |
| DE60139639D1 (de) | 2000-12-08 | 2009-10-01 | Takeda Pharmaceutical | Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung |
| UA105794C2 (uk) | 2009-06-26 | 2014-06-25 | Новартіс Аг | 1,3-ДИЗАМІЩЕНІ ПОХІДНІ ІМІДАЗОЛІДИН-2-ОНУ ЯК ІНГІБІТОРИ Cyp17 |
| US9132105B2 (en) | 2010-08-04 | 2015-09-15 | Pellficure Pharmaceuticals, Inc. | Treatment of prostate carcinoma |
| US8946260B2 (en) | 2010-09-16 | 2015-02-03 | Novartis Ag | 17α-hydroxylase/C17,20-lyase inhibitors |
| ES2656218T3 (es) | 2011-04-28 | 2018-02-26 | Novartis Ag | Inhibidores de 17 alfa-hidroxilasa/C17,20-liasa |
| CA2902335C (en) | 2013-03-14 | 2021-09-14 | Pellficure Pharmaceuticals, Inc. | Novel therapy for prostate carcinoma |
| US10093620B2 (en) | 2014-09-12 | 2018-10-09 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| EP3528799A1 (en) | 2016-10-24 | 2019-08-28 | Pellficure Pharmaceuticals, Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL302932A (xx) * | 1962-12-31 | |||
| US4891367A (en) * | 1987-04-22 | 1990-01-02 | Merrell Dow Pharmaceuticals Inc. | 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors |
-
1988
- 1988-04-18 NZ NZ224288A patent/NZ224288A/xx unknown
- 1988-04-18 AU AU14719/88A patent/AU606677B2/en not_active Ceased
- 1988-04-18 CA CA000564364A patent/CA1326234C/en not_active Expired - Fee Related
- 1988-04-18 ZA ZA882717A patent/ZA882717B/xx unknown
- 1988-04-19 PH PH36817A patent/PH24090A/en unknown
- 1988-04-20 IL IL86139A patent/IL86139A/xx unknown
- 1988-04-21 ES ES198888106397T patent/ES2038712T3/es not_active Expired - Lifetime
- 1988-04-21 EP EP88106397A patent/EP0288053B1/en not_active Expired - Lifetime
- 1988-04-21 DE DE8888106397T patent/DE3864725D1/de not_active Expired - Fee Related
- 1988-04-21 HU HU882029A patent/HU198511B/hu not_active IP Right Cessation
- 1988-04-21 KR KR1019880004512A patent/KR960015037B1/ko not_active IP Right Cessation
- 1988-04-21 DK DK217588A patent/DK217588A/da not_active Application Discontinuation
- 1988-04-21 FI FI881877A patent/FI88397C/fi not_active IP Right Cessation
- 1988-04-21 AT AT88106397T patent/ATE67211T1/de not_active IP Right Cessation
- 1988-04-21 PT PT87294A patent/PT87294B/pt not_active IP Right Cessation
- 1988-04-21 CN CN198888102176A patent/CN88102176A/zh active Pending
- 1988-04-21 JP JP63096969A patent/JP2711672B2/ja not_active Expired - Fee Related
- 1988-04-21 NO NO881746A patent/NO169346C/no unknown
-
1991
- 1991-09-12 GR GR91401315T patent/GR3002713T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO169346C (no) | 1992-06-10 |
| JPS63284195A (ja) | 1988-11-21 |
| GR3002713T3 (en) | 1993-01-25 |
| IL86139A0 (en) | 1988-11-15 |
| PH24090A (en) | 1990-03-05 |
| CA1326234C (en) | 1994-01-18 |
| NO169346B (no) | 1992-03-02 |
| ZA882717B (en) | 1988-10-17 |
| PT87294A (pt) | 1988-05-01 |
| KR880012633A (ko) | 1988-11-28 |
| JP2711672B2 (ja) | 1998-02-10 |
| KR960015037B1 (ko) | 1996-10-24 |
| HUT47307A (en) | 1989-02-28 |
| AU606677B2 (en) | 1991-02-14 |
| EP0288053B1 (en) | 1991-09-11 |
| FI88397B (fi) | 1993-01-29 |
| AU1471988A (en) | 1988-10-27 |
| HU198511B (en) | 1989-10-30 |
| CN88102176A (zh) | 1988-11-23 |
| PT87294B (pt) | 1992-08-31 |
| DK217588A (da) | 1988-10-23 |
| DK217588D0 (da) | 1988-04-21 |
| FI881877A (fi) | 1988-10-23 |
| NZ224288A (en) | 1989-12-21 |
| DE3864725D1 (de) | 1991-10-17 |
| FI881877A0 (fi) | 1988-04-21 |
| ATE67211T1 (de) | 1991-09-15 |
| NO881746L (no) | 1988-10-24 |
| EP0288053A1 (en) | 1988-10-26 |
| NO881746D0 (no) | 1988-04-21 |
| FI88397C (fi) | 1993-05-10 |
| ES2038712T3 (es) | 1993-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL86139A (en) | 17-(cyclopropylamino) androst-5-en-3 ol and pharmaceutical compositions containing them, useful as c17-20 lyase inhibitors | |
| AU628209B2 (en) | 4-substituted 17beta-(cyclopropylamino)androst-5-en-3beta-ol and related compounds useful as c17-20 lyase inhibitors | |
| IL95359A0 (en) | 4-substituted 17beta-(cyclopropylamino-androst-5-en-3beta-ol and related compounds useful as c17-20 lyase inhibitors | |
| HU9601113D0 (en) | Delta16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors, pharmaceutical compositions containing them and process for their production | |
| HU912486D0 (en) | Process for producing ethers and thioethers of piperidyl | |
| IL86140A (en) | 17-(cyclopropyloxy) androst-5-en-3-ol and pharmaceutical compositions useful as c17-20 lyase inhibitors | |
| EP0305181A3 (en) | Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin | |
| HUT57209A (en) | Process for producing hydroxymethyl-indolizidine and kinolizidine derivatives and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of name of proprietor(s) |
Owner name: AVENTIS INC. Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC. |